INFINITY-Extension
Showing 1 - 25 of 3,962
Long-Term Follow-up Study of ADVM-022 in DME (INFINITY-EXT)
Enrolling by invitation
- Diabetic Macular Edema
- Diabetic Retinopathy
- ADVM-022
-
Beverly Hills, California
- +6 more
Nov 4, 2022
Opioid-use Disorder Trial in Pittsburgh (DBS of the NAc)
Recruiting
- Opioid-use Disorder
- DBS of the NAc
-
Pittsburgh, PennsylvaniaAHN Allegheny General Hospital
Feb 9, 2022
Bilateral Vocal Fold Paralysis (BVFP) Trial (Investigational device)
Active, not recruiting
- Bilateral Vocal Fold Paralysis (BVFP)
- Investigational device
- (no location specified)
Mar 26, 2022
Parkinson Disease Trial in Worldwide (IPX203 140 mg, IPX203 210 mg, IPX203 280 mg)
Completed
- Parkinson Disease
- IPX203 140 mg
- +3 more
-
Phoenix, Arizona
- +97 more
Apr 5, 2022
Parkinson Disease Trial in Worldwide (Omnidirectional stimulation, Directional stimulation)
Completed
- Parkinson Disease
- Omnidirectional stimulation
- Directional stimulation
-
Sacramento, California
- +48 more
Jun 28, 2022
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia, MDS Trial in Canada, United States (ASTX727)
Enrolling by invitation
- Acute Myeloid Leukemia
- +2 more
-
Fountain Valley, California
- +28 more
Nov 18, 2022
Metastatic Pancreatic Adenocarcinoma Trial in Worldwide (Irinotecan liposome injection, Folinic Acid, 5-Fluorouracil)
Recruiting
- Metastatic Pancreatic Adenocarcinoma
- Irinotecan liposome injection
- +2 more
-
Bedford Park, Australia
- +35 more
Jan 24, 2023
Tumors Trial in United States (Niraparib Tablet, Niraparib Capsule)
Active, not recruiting
- Neoplasms
- Niraparib Tablet
- Niraparib Capsule
-
Encinitas, California
- +15 more
Sep 7, 2022
Locally Advanced or Metastatic Malignant Solid Tumors Trial in Beijing (WJ05129)
Not yet recruiting
- Locally Advanced or Metastatic Malignant Solid Tumors
-
Beijing, Beijing, ChinaCancer Institute & Hospital Chinese Academy of Medical Sciences
Apr 6, 2022
INFINITY™ With ADAPTIS™ Technology Study
Recruiting
- Arthritis, Rheumatoid
- INFINITY™ with ADAPTIS™ Technology Total Ankle System
-
Gilbert, Arizona
- +11 more
Jan 3, 2023
Myotonic Dystrophy Type 1 (DM1) Trial in Auckland (DYNE-101, Placebo)
Not yet recruiting
- Myotonic Dystrophy Type 1 (DM1)
- DYNE-101
- Placebo
-
Auckland, New ZealandUniversity of Auckland Research Centre
Jul 28, 2022
Essential Tremor, Parkinson's Disease Trial in Albany, San Antonio, Spokane (Clinician programmer electrode screening mode tool)
Completed
- Essential Tremor
- Parkinson's Disease
- Clinician programmer electrode screening mode tool
-
Albany, New York
- +2 more
Mar 28, 2022
Migraine in Children, Migraine Trial in United States (Eptinezumab)
Active, not recruiting
- Migraine in Children
- Migraine
-
Stamford, Connecticut
- +8 more
Nov 14, 2022
Alzheimer Trial in Worldwide (Gantenerumab, Placebo)
Active, not recruiting
- Alzheimer Disease
- Gantenerumab
- Placebo
-
Phoenix, Arizona
- +156 more
Jul 4, 2022
Coronary Artery Disease, Ischemic Heart Disease Trial in Sweden (DynamX Bioadaptor, Resolute Onyx)
Recruiting
- Coronary Artery Disease
- Ischemic Heart Disease
- DynamX Bioadaptor
- Resolute Onyx
-
Eskilstuna, Sweden
- +18 more
Jul 18, 2022
Adalimumab Trial in Cypress, South Miami, Salt Lake City (ABP 501-HCF, ABP 501-LCF)
Completed
- Adalimumab
- ABP 501-HCF
- ABP 501-LCF
-
Cypress, California
- +2 more
Jun 9, 2023
UK Infinity, Post-Market Clinical Follow-up Study
Active, not recruiting
- Arthritis, Rheumatoid
-
Torquay, Devon, United Kingdom
- +11 more
Feb 7, 2022
Frontotemporal Dementia Trial in Merthyr Tydfil (DNL593, Placebo)
Recruiting
- Frontotemporal Dementia
- DNL593
- Placebo
-
Merthyr Tydfil, Wales, United KingdomClinical Site
Feb 26, 2022